心房心肌病:标志物与结局
15.7%个体有至少1个标志物,2.3%有至少2个。标志物与三种结局均相关,且与临床和遗传风险因素有叠加效应。
要点
- 心房心肌病标志物在人群中常见,约七分之一个体至少有一个标志物。
- 标志物数量与房颤风险呈量效关系,≥2个标志物时风险显著增高。
- 标志物还可预测心衰和卒中,提示心房心肌病是三种结局的共同基础。
核心结论
- 心房心肌病标志物与房颤、心衰和卒中相关,支持其作为三种结局的共同基础。
研究设计与样本
- 采用逻辑回归评估心房心肌病风险因素,用Cox回归和累积发病率模型评估结局。
主要发现
- 年龄、冠心病和高血压与心房心肌病持续相关。
- 加入心房心肌病标志物后净重分类改善为13.7%(95%CI 9.2%-18.3%)。
临床怎么用
- 在心房颤动风险评估中,可考虑结合心房心肌病标志物以提高风险分层准确性。
- 对于有心房心肌病标志物的个体,应关注心衰和卒中的预防。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Atrial cardiomyopathy (AtCM) is increasingly recognized as an important substrate for atrial fibrillation (AF). This study aimed to examine potential markers and risk factors of AtCM, and associations with incident AF, heart failure (HF), and stroke. METHODS: Individuals from the UK Biobank with cardiac magnetic resonance imaging and electrocardiographic information were included. Atrial cardiomyopathy markers included left atrial dilation, left atrial mechanical dysfunction, P-wave prolongation, and abnormal P-wave terminal force. Risk factors for AtCM were assessed using logistic regressions. Incident AF, HF, and stroke according to AtCM markers were assessed in multivariable Cox-regression and cumulative incidence models. AF risk according to AtCM markers, clinical and genetic risk factors was evaluated by integrating the HARMS2-AF score and a polygenic risk score for AF. We used net reclassification improvement (NRI) to evaluate reclassification of risk when considering AtCM markers. RESULTS: Among 26 467 individuals, 4145 (15.7%) had ≥1 marker and 619 (2.3%) had ≥2 markers of AtCM. Age, coronary artery disease, and hypertension were consistently associated with AtCM. Having one AtCM marker conferred a hazard ratio (HR) for AF of 1.88 [95% confidence interval (CI): 1.54-2.31; P < .001], with higher rates observed in individuals with ≥2 markers (HR: 4.59; 95% CI: 3.52-5.99; P < .001). Addition of AtCM markers was associated with an NRI of 13.7% (95% CI: 9.2%-18.3%). Integration of clinical and genetic risk factors indicated an additive effect on AF rates. Having ≥2 markers associated with HF (HR: 3.08, 95% CI: 2.03-4.66, P < .001), and stroke (HR: 3.07, 95% CI: 1.78-5.28, P < .001). CONCLUSIONS: One in seven individuals had at least one marker of AtCM. Atrial cardiomyopathy markers were associated with AF, HF, and stroke, supporting AtCM as a common substrate for all three outcomes.
引用
- Vad OB, van Vreeswijk N, Yassin AS, et al. Atrial cardiomyopathy: markers and outcomes. Eur Heart J. 2026. PMID: 41092306. doi:10.1093/eurheartj/ehaf793
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。